178 related articles for article (PubMed ID: 32828222)
1. Individuals' Preferences for Esophageal Cancer Screening: A Discrete Choice Experiment.
Peters Y; van Grinsven E; van de Haterd M; van Lankveld D; Verbakel J; Siersema PD
Value Health; 2020 Aug; 23(8):1087-1095. PubMed ID: 32828222
[TBL] [Abstract][Full Text] [Related]
2. Public Preferences and Predicted Uptake for Esophageal Cancer Screening Strategies: A Labeled Discrete Choice Experiment.
Peters Y; Siersema PD
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00260. PubMed ID: 33105164
[TBL] [Abstract][Full Text] [Related]
3. Preferences for Surveillance of Barrett's Oesophagus: a Discrete Choice Experiment.
Bulamu NB; Chen G; Bright T; Ratcliffe J; Chung A; Fraser RJL; Törnqvist B; Watson DI
J Gastrointest Surg; 2019 Jul; 23(7):1309-1317. PubMed ID: 30478530
[TBL] [Abstract][Full Text] [Related]
4. Public Preference Heterogeneity and Predicted Uptake Rate of Upper Gastrointestinal Cancer Screening Programs in Rural China: Discrete Choice Experiments and Latent Class Analysis.
Liu R; Li Q; Li Y; Wei W; Ma S; Wang J; Zhang N
JMIR Public Health Surveill; 2023 Jul; 9():e42898. PubMed ID: 37428530
[TBL] [Abstract][Full Text] [Related]
5. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
Benning TM; Dellaert BG; Severens JL; Dirksen CD
Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
[TBL] [Abstract][Full Text] [Related]
6. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Model to Determine Risk of Progression of Barrett's Esophagus to Neoplasia.
Parasa S; Vennalaganti S; Gaddam S; Vennalaganti P; Young P; Gupta N; Thota P; Cash B; Mathur S; Sampliner R; Moawad F; Lieberman D; Bansal A; Kennedy KF; Vargo J; Falk G; Spaander M; Bruno M; Sharma P
Gastroenterology; 2018 Apr; 154(5):1282-1289.e2. PubMed ID: 29273452
[TBL] [Abstract][Full Text] [Related]
8. Laryngopharyngeal reflux symptoms better predict the presence of esophageal adenocarcinoma than typical gastroesophageal reflux symptoms.
Reavis KM; Morris CD; Gopal DV; Hunter JG; Jobe BA
Ann Surg; 2004 Jun; 239(6):849-56; discussion 856-8. PubMed ID: 15166964
[TBL] [Abstract][Full Text] [Related]
9. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
10. Interactive decision support for esophageal adenocarcinoma screening and surveillance.
Vaughan TL; Onstad L; Dai JY
BMC Gastroenterol; 2019 Jun; 19(1):109. PubMed ID: 31248371
[TBL] [Abstract][Full Text] [Related]
11. Eliciting population preferences for mass colorectal cancer screening organization.
Nayaradou M; Berchi C; Dejardin O; Launoy G
Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
[TBL] [Abstract][Full Text] [Related]
12. Model for Identifying Individuals at Risk for Esophageal Adenocarcinoma.
Kunzmann AT; Thrift AP; Cardwell CR; Lagergren J; Xie S; Johnston BT; Anderson LA; Busby J; McMenamin ÚC; Spence AD; Coleman HG
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1229-1236.e4. PubMed ID: 29559360
[TBL] [Abstract][Full Text] [Related]
13. Colorectal Cancer Screening: Preferences, Past Behavior, and Future Intentions.
Mansfield C; Ekwueme DU; Tangka FKL; Brown DS; Smith JL; Guy GP; Li C; Hauber B
Patient; 2018 Dec; 11(6):599-611. PubMed ID: 29740804
[TBL] [Abstract][Full Text] [Related]
14. [Screening for adenocarcinoma in Barrett's esophagus: yes or no, when and how?].
Sostres C; Lacarta P; Lanas A
Gastroenterol Hepatol; 2013 Oct; 36(8):520-6. PubMed ID: 23453559
[TBL] [Abstract][Full Text] [Related]
15. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
Vass CM; Rigby D; Payne K
Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
[TBL] [Abstract][Full Text] [Related]
16. What determines individuals' preferences for colorectal cancer screening programmes? A discrete choice experiment.
van Dam L; Hol L; de Bekker-Grob EW; Steyerberg EW; Kuipers EJ; Habbema JD; Essink-Bot ML; van Leerdam ME
Eur J Cancer; 2010 Jan; 46(1):150-9. PubMed ID: 19683432
[TBL] [Abstract][Full Text] [Related]
17. Men's preferences and trade-offs for prostate cancer screening: a discrete choice experiment.
Howard K; Salkeld GP; Patel MI; Mann GJ; Pignone MP
Health Expect; 2015 Dec; 18(6):3123-35. PubMed ID: 25382490
[TBL] [Abstract][Full Text] [Related]
18. Preferences of first-degree relatives of gastric cancer patients for gastric cancer screening: a discrete choice experiment.
Li HQ; Xue H; Yuan H; Wan GY; Zhang XY
BMC Cancer; 2021 Aug; 21(1):959. PubMed ID: 34445987
[TBL] [Abstract][Full Text] [Related]
19. Risk stratification of patients with barrett's esophagus and low-grade dysplasia or indefinite for dysplasia.
Thota PN; Lee HJ; Goldblum JR; Liu X; Sanaka MR; Gohel T; Kanadiya M; Lopez R
Clin Gastroenterol Hepatol; 2015 Mar; 13(3):459-465.e1. PubMed ID: 25102445
[TBL] [Abstract][Full Text] [Related]
20. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
Sicsic J; Pelletier-Fleury N; Moumjid N
Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
